Skip to Main Content

Paper Details

Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
Genome Med
16
2022
EC, EC PDX models, Endometrial cancer, HR, HR deficiency, PARP, PARPi, PDX, PDX lineages, PDX models, PDXs, Patient, carcinosarcoma, carcinosarcomas, copy, copy number high models, endometrial cancer, grade 2/3 tumors, gynecological cancer, mismatch, mismatch-, mismatch-repair deficient molecular subtypes, molecular subtype, p53, p53-mutant, patient, primary, talazoparib, tumor, tumors, uterine carcinosarcomas
Author NameAffiliation
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Ann-Marie PatchThe University of Queensland
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Ann-Marie PatchThe University of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellThe University of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellThe University of Queensland
  • 1 - 12

Datasets

Release 1.2